Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Intellia Therapeutics has entered into a $400 million senior secured term loan facility with OrbiMed, providing financial flexibility to advance its CRISPR gene-editing therapies, including the anticipated U.S. approval and commercial launch of lonvoguran ziclumeran for hereditary angioedema and progress in transthyretin amyloidosis treatments. The…
Wacker Chemie shares fell after a report that the company has lost the last two customers for its Charleston, Tennessee polysilicon plant, putting the roughly 600-worker facility at risk of closure. The departures followed a White House proclamation on August 6 introducing a price floor and tariff on imported polysilicon, which the company says doe…
Nano-X Imaging Ltd. (NASDAQ: NNOX) announced a new distribution agreement between its U.S. subsidiary, Nanox Impact Inc., and Associated X-Ray Imaging Corp., a leading New England medical imaging provider. This partnership will leverage Associated X-Ray's regional presence to market, distribute, and support Nanox's FDA-cleared digital 3D tomosynthe…
OFA Group (NASDAQ:OFAL) shares rose sharply in premarket trading after the company disclosed that its QikBIM artificial intelligence platform attracted 281,665 content views and converted its first paying subscribers within 90 days of launch. The firm reported substantial spikes in site traffic and session activity during an eight-day campaign, and…
Tarsus Pharmaceuticals has completed its acquisition of Alkeus Pharmaceuticals, gaining worldwide rights to ALK-001, a Phase 3 investigational oral drug targeting Stargardt disease, a rare retinal disorder with no FDA-approved treatments. ALK-001 has several FDA designations including Breakthrough Therapy and Orphan Drug, and topline Phase 3 data f…
Canada shed 41,700 positions in August, driven primarily by losses in full-time work and concentrated declines across service-producing industries. The unemployment rate remained unchanged at 6.4% even as hourly wage growth slowed and the labour force contracted for the first time since February. The report arrives just before higher U.S. tariffs a…
Wacker Chemie shares fell after reports that the company is weighing the closure of its Charleston, Tennessee polysilicon plant, which employs roughly 600 people and reportedly lost its two remaining customers following U.S. trade measures intended to encourage purchases of American-made polysilicon. The company says it is still assessing the polic…
Donegal Mutual Insurance Co systematically increased its equity position in Donegal Group Inc through targeted share purchases in early September 2026. The transaction coincides with a period of strengthened operational efficiency, robust quarterly earnings expansion, and a combined ratio improvement that underscores enhanced underwriting disciplin…
Virco Mfg. Corporation reported a 6.1% decline in revenue through the first six months of 2026 to $118.2 million, reflecting ongoing market rebalancing in the school furniture sector. Despite lower sales, the company maintained strong operating income above its long-term average and declared a quarterly dividend. Recent budget approvals in public s…
The Trade Desk said it will cut roughly 15% of its workforce as part of a realignment intended to focus resources on higher-priority growth areas and boost operational effectiveness. The plan, disclosed on September 3, 2026, is expected to be substantially complete in the third quarter of 2026. The company estimates cash restructuring and related c…
Options activity in Equinor ASA showed a heavy concentration of puts on September 4, 2026, with 6,000 Oct. 16 NOK355 contracts traded amid zero prior open interest. While the one-sided flow points to downside concern, a decline in three-month volatility and a slightly lower 90/110 skew indicate the broader options market moved less defensively, lea…
Morgan Stanley has added Accor to its European travel and leisure Top Picks list and retained IAG, upgrading Accor to overweight and keeping IAG at overweight. The broker raised Accor’s price target to €55 and maintained IAG’s at €5.80, each implying roughly 18% upside, while highlighting expected cash returns, buybacks and structural revenue impro…
Edible Garden AG Incorporated (Nasdaq: EDBL) announced the launch of what it believes to be the controlled environment agriculture industry's first verified USDA Organic basil. The product is now shipping to Wakefern Food Corp. for distribution in participating ShopRite stores ahead of Labor Day, utilizing Wakefern’s logistics network to enhance su…
McDonald’s shares are trading near their 52-week low, yet technical indicators across daily, weekly and monthly horizons remain in Strong Sell territory. While revenue growth and margins show durability, valuation and execution questions constrain the upside. The stock is better suited for a watchlist until price action stabilizes and momentum impr…
Tesla shares fell 3.0% in pre-market trading to $365 after the company's Cybercab reveal in Austin, Texas, immediately prompted a formal audit by the U.S. National Highway Traffic Safety Administration into roughly 1,000 vehicles. Investors reacted to a launch that failed to deliver expected detail on deployment scale and timing, while Tesla’s init…
Citadel has been in discussions to acquire U.S. oil production assets and was among bidders for WildFire Energy, which was sold to Magnolia Oil & Gas for $4.06 billion. The firm has recently engaged multiple private equity owners of exploration and production companies about potential purchases as elevated crude prices and Middle East tensions incr…
Royal Gold (RGLD) owns precious-metal stream and royalty interests that deliver operating leverage to metals prices without mine-site risk. At a current price of $264.93 and a market cap near $22.45B, the company trades at roughly 30x earnings and under 3x book while carrying almost no debt. This trade idea buys RGLD near $264.93 with a stop at $24…
NANO Nuclear Energy Inc., a Nasdaq-listed advanced nuclear technology company, announced a non-binding Memorandum of Understanding with Enveniam to explore collaboration on nuclear fuel transportation, conversion, microreactor commercialization, advanced manufacturing, and energy solutions for data centers and remote communities. The partnership ai…
Rein Therapeutics announced it will present a late-breaking poster on LTI-03, its novel inhaled peptide therapy for idiopathic pulmonary fibrosis, at the European Respiratory Society (ERS) 2026 Congress. The presentation will detail data from the RENEW Phase 2 trial evaluating safety and efficacy of LTI-03, which aims to inhibit lung fibrosis and p…
Nautilus Biotechnology announced a pioneering peer-reviewed study published in Nature Methods demonstrating its Iterative Mapping technology's ability to quantify distinct tau proteoforms at single-molecule resolution. This novel measurement reveals disease-associated ordered modification patterns crucial for understanding Alzheimer's disease and r…
Hurco Companies, Inc. reported a net income of $2.314 million for Q3 fiscal 2026, a significant turnaround from a net loss in the same period last year. Sales increased 3% year-over-year, driven by higher machine sales in the U.S. and Asia Pacific regions and a stronger product mix. Gross margin expanded by 800 basis points to 28%, aided by cost co…
Alumis Inc., a late-stage biopharmaceutical company specializing in next-generation targeted therapies for immune-mediated diseases, announced its participation in several prominent investor conferences throughout September 2026. The company plans to present updates on its pipeline, including oral TYK2 inhibitors envudeucitinib and A-005, targeting…
OFA Group (Nasdaq: OFAL) announced that its AI-powered Building Information Modeling platform, QikBIM, has rapidly gained over 281,000 views and thousands of new followers within 90 days of launch. The platform reached nearly 187,000 architecture, engineering, and construction professionals in an eight-day paid campaign, significantly exceeded indu…
Iovance Biotherapeutics, a biotechnology company specializing in tumor infiltrating lymphocyte (TIL) therapies for cancer, announced that its senior leadership will present at the Wells Fargo 21st Annual Healthcare Conference and the H.C. Wainwright 28th Annual Global Investment Conference. These presentations are part of the company's ongoing effo…
Intellia Therapeutics, a clinical-stage biopharmaceutical company specializing in CRISPR gene editing, will present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026. The presentation will be webcast live and available for replay on the company's website.
